{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:35:53Z","timestamp":1747182953657,"version":"3.40.5"},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust NZ J Obst Gynaeco"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Peritonectomy and hyperthermic intraperitoneal chemotherapy (<jats:styled-content style=\"fixed-case\">HIPEC<\/jats:styled-content>) is used in specialised units outside of gynaecological cancer centres in Australia and New Zealand to treat advanced epithelial ovarian cancer (<jats:styled-content style=\"fixed-case\">AEOC<\/jats:styled-content>). There is significant equipoise toward this treatment by gynaecological oncologists (<jats:styled-content style=\"fixed-case\">CGO<\/jats:styled-content>s).<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To determine the attitudes and preferences of <jats:styled-content style=\"fixed-case\">CGO<\/jats:styled-content>s toward peritonectomy and <jats:styled-content style=\"fixed-case\">HIPEC<\/jats:styled-content> for the treatment of <jats:styled-content style=\"fixed-case\">AEOC<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>A questionnaire was sent to all 53 <jats:styled-content style=\"fixed-case\">CGO<\/jats:styled-content>s in Australia and New Zealand asking their opinions about peritonectomy and <jats:styled-content style=\"fixed-case\">HIPEC<\/jats:styled-content> for the treatment of <jats:styled-content style=\"fixed-case\">AEOC<\/jats:styled-content>. Data collected included surgeon demographics, individual surgical practices, and willingness of <jats:styled-content style=\"fixed-case\">CGO<\/jats:styled-content>s to refer patients for peritonectomy or <jats:styled-content style=\"fixed-case\">HIPEC<\/jats:styled-content>. Potential factors influencing this decision were investigated using \u03c7<jats:sup>2<\/jats:sup> tests and logistic regression analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Response rate was 89%. While 68% of <jats:styled-content style=\"fixed-case\">CGO<\/jats:styled-content>s would refer a patient for peritonectomy, most cases would be recurrent tumour of borderline or mucinous histology. Only 13% would refer a case of primary stage 3 <jats:styled-content style=\"fixed-case\">EOC<\/jats:styled-content>, even if predicting they cannot completely resect the tumour. This was due to concerns around morbidity and mortality, and a preference for neoadjuvant chemotherapy. In regard to <jats:styled-content style=\"fixed-case\">HIPEC<\/jats:styled-content>, 61% of <jats:styled-content style=\"fixed-case\">CGO<\/jats:styled-content>s were unsure about its use, due to reported lack of evidence, and potential morbidity. <jats:styled-content style=\"fixed-case\">CGO<\/jats:styled-content>s of female gender were more likely to recommend peritonectomy and <jats:styled-content style=\"fixed-case\">HIPEC<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">CGO<\/jats:styled-content>s would refer only selected cases of <jats:styled-content style=\"fixed-case\">AEOC<\/jats:styled-content> for peritonectomy or <jats:styled-content style=\"fixed-case\">HIPEC<\/jats:styled-content>, due to concerns around insufficient evidence, and potential morbidity. The results of large well\u2010conducted clinical trials will help determine the future of peritonectomy and <jats:styled-content style=\"fixed-case\">HIPEC<\/jats:styled-content> for the treatment of <jats:styled-content style=\"fixed-case\">AEOC<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ajo.12972","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T01:13:19Z","timestamp":1553735599000},"page":"457-462","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Peritonectomy and hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer: What gynaecological oncologists really think"],"prefix":"10.1111","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7036-8968","authenticated-orcid":false,"given":"Rhonda","family":"Farrell","sequence":"first","affiliation":[{"name":"Prince of Wales Private Hospital  Sydney New South Wales Australia"},{"name":"Department of Surgery St George Hospital, UNSW  Sydney New South Wales Australia"},{"name":"Chris O\u2019Brien Lifehouse Sydney  New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"Australian Institute of Health and Welfare 2017. Cancer in Australia 2017. Cancer series no. 101. Cat. no. CAN 100.Canberra:AIHW."},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja14.00132"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2013.24.4.359"},{"key":"e_1_2_6_5_1","first-page":"246","article-title":"Peritonectomy procedures","volume":"134","author":"Sugarbaker PH","year":"2007","journal-title":"Cancer Treat Res"},{"key":"e_1_2_6_6_1","first-page":"CD007565","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer","volume":"8","author":"Elattar A","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.05.040"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.03.018"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2011.02.014"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000001247"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708618"},{"key":"e_1_2_6_12_1","unstructured":"MilneP PaulT ReidMet\u00a0al.NSW peritonectomy services planning prepared for NSW Ministry for Health; Sep2015."},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.5501"},{"issue":"15","key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1200\/JCO.2018.36.15_suppl.5501","article-title":"A phase III randomized controlled trial of secondary surgical cytoreduction (SSC) followed by platinum\u2010based combination chemotherapy (PBC), with or without bevacizumab (B) in platinum\u2010sensitive, recurrent ovarian cancer (PSOC): a NRG Oncology\/Gynecologic Oncology Group (GOG) study","volume":"36","author":"Coleman RL","year":"2018","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000473"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/his.13324"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2000.01553.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2016.03.017"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2015.08.172"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908806"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62223-6"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.01.017"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajo.12972","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajo.12972","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajo.12972","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T21:28:52Z","timestamp":1694381332000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/ajo.12972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1111\/ajo.12972"],"URL":"https:\/\/doi.org\/10.1111\/ajo.12972","archive":["Portico"],"relation":{},"ISSN":["0004-8666","1479-828X"],"issn-type":[{"type":"print","value":"0004-8666"},{"type":"electronic","value":"1479-828X"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"assertion":[{"value":"2018-11-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}